149 related articles for article (PubMed ID: 34247514)
1. The clinical value of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) semi-quantitative parameters in monitoring neoadjuvant chemotherapy response of osteosarcoma.
Zeng YN; Zhang BT; Song T; Peng JF; Wang JT; Yuan Q; Tan MY
Acta Radiol; 2022 Aug; 63(8):1077-1085. PubMed ID: 34247514
[TBL] [Abstract][Full Text] [Related]
2. Integrating dynamic contrast-enhanced magnetic resonance imaging and diffusion kurtosis imaging for neoadjuvant chemotherapy assessment of nasopharyngeal carcinoma.
Zheng D; Lai G; Chen Y; Yue Q; Liu X; Chen X; Chen W; Chan Q; Chen Y
J Magn Reson Imaging; 2018 Nov; 48(5):1208-1216. PubMed ID: 29693765
[TBL] [Abstract][Full Text] [Related]
3. Machine Learning-Based Radiomics Nomogram With Dynamic Contrast-Enhanced MRI of the Osteosarcoma for Evaluation of Efficacy of Neoadjuvant Chemotherapy.
Zhang L; Ge Y; Gao Q; Zhao F; Cheng T; Li H; Xia Y
Front Oncol; 2021; 11():758921. PubMed ID: 34868973
[TBL] [Abstract][Full Text] [Related]
4. Intravoxel incoherent motion and dynamic contrast-enhanced magnetic resonance imaging for neoadjuvant chemotherapy response evaluation in patients with osteosarcoma.
Yin P; Xu J; Sun X; Liu T; Chen L; Hong N
Eur J Radiol; 2023 May; 162():110790. PubMed ID: 36963332
[TBL] [Abstract][Full Text] [Related]
5. Early prediction of pathologic complete response of breast cancer after neoadjuvant chemotherapy using longitudinal ultrafast dynamic contrast-enhanced MRI.
Cao Y; Wang X; Li L; Shi J; Zeng X; Huang Y; Chen H; Jiang F; Yin T; Nickel D; Zhang J
Diagn Interv Imaging; 2023 Dec; 104(12):605-614. PubMed ID: 37543490
[TBL] [Abstract][Full Text] [Related]
6. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for pretreatment prediction of neoadjuvant chemotherapy response in locally advanced hypopharyngeal cancer.
Guo W; Zhang Y; Luo D; Yuan H
Br J Radiol; 2020 Nov; 93(1115):20200751. PubMed ID: 32915647
[No Abstract] [Full Text] [Related]
7. Prediction of pathological complete response to neoadjuvant chemotherapy in patients with breast cancer using a combination of contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging.
Han X; Yang H; Jin S; Sun Y; Zhang H; Shan M; Cheng W
Cancer Med; 2023 Jan; 12(2):1389-1398. PubMed ID: 35822639
[TBL] [Abstract][Full Text] [Related]
8. Early Prediction of Response to Neoadjuvant Chemotherapy Using Dynamic Contrast-Enhanced MRI and Ultrasound in Breast Cancer.
Kim Y; Kim SH; Song BJ; Kang BJ; Yim KI; Lee A; Nam Y
Korean J Radiol; 2018; 19(4):682-691. PubMed ID: 29962874
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the efficacy of neoadjuvant chemotherapy for breast cancer using diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging.
Xu HD; Zhang YQ
Neoplasma; 2017; 64(3):430-436. PubMed ID: 28253722
[TBL] [Abstract][Full Text] [Related]
10. Early assessment of breast cancer response to neoadjuvant chemotherapy by semi-quantitative analysis of high-temporal resolution DCE-MRI: preliminary results.
Abramson RG; Li X; Hoyt TL; Su PF; Arlinghaus LR; Wilson KJ; Abramson VG; Chakravarthy AB; Yankeelov TE
Magn Reson Imaging; 2013 Nov; 31(9):1457-64. PubMed ID: 23954320
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of response to neoadjuvant chemotherapy in osteosarcoma using dynamic contrast-enhanced MRI: development and external validation of a model.
Kalisvaart GM; Van Den Berghe T; Grootjans W; Lejoly M; Huysse WCJ; Bovée JVMG; Creytens D; Gelderblom H; Speetjens FM; Lapeire L; van de Sande MAJ; Sys G; de Geus-Oei LF; Verstraete KL; Bloem JL
Skeletal Radiol; 2024 Feb; 53(2):319-328. PubMed ID: 37464020
[TBL] [Abstract][Full Text] [Related]
12. Early responses assessment of neoadjuvant chemotherapy in nasopharyngeal carcinoma by serial dynamic contrast-enhanced MR imaging.
Zheng D; Yue Q; Ren W; Liu M; Zhang X; Lin H; Lai G; Chen W; Chan Q; Chen Y
Magn Reson Imaging; 2017 Jan; 35():125-131. PubMed ID: 27587228
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Tumor Response After Neoadjuvant Chemotherapy in Breast Cancer Patients: Correlation Between Dynamic Contrast-enhanced Magnetic Resonance Imaging and Pathologic Tumor Cellularity.
Choi WJ; Kim WK; Shin HJ; Cha JH; Chae EY; Kim HH
Clin Breast Cancer; 2018 Feb; 18(1):e115-e121. PubMed ID: 28890184
[TBL] [Abstract][Full Text] [Related]
14. [Preliminary study of semi-quantitative and quantitative dynamic contrast-enhanced MRI in evaluating the response to concurrent chemoradiotherapy in patients with non-small cell lung cancer].
Xiuli T; Han O; Ning W; Li L; Feng Y; Ying S; Peihua W; Lü L
Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):272-7. PubMed ID: 26462891
[TBL] [Abstract][Full Text] [Related]
15. Meta-Analysis of Quantitative Dynamic Contrast-Enhanced MRI for the Assessment of Neoadjuvant Chemotherapy in Breast Cancer.
Jun W; Cong W; Xianxin X; Daqing J
Am Surg; 2019 Jun; 85(6):645-653. PubMed ID: 31267907
[TBL] [Abstract][Full Text] [Related]
16. Quantitative evaluation of breast cancer response to neoadjuvant chemotherapy by diffusion tensor imaging: Initial results.
Furman-Haran E; Nissan N; Ricart-Selma V; Martinez-Rubio C; Degani H; Camps-Herrero J
J Magn Reson Imaging; 2018 Apr; 47(4):1080-1090. PubMed ID: 28901594
[TBL] [Abstract][Full Text] [Related]
17. Early prediction of pathological complete response to neoadjuvant chemotherapy combining DCE-MRI and apparent diffusion coefficient values in breast Cancer.
Liang X; Chen X; Yang Z; Liao Y; Wang M; Li Y; Fan W; Dai Z; Zhang Y
BMC Cancer; 2022 Dec; 22(1):1250. PubMed ID: 36460972
[TBL] [Abstract][Full Text] [Related]
18. Multiparametric MRI with diffusion-weighted imaging in predicting response to chemotherapy in cases of osteosarcoma and Ewing's sarcoma.
Saleh MM; Abdelrahman TM; Madney Y; Mohamed G; Shokry AM; Moustafa AF
Br J Radiol; 2020 Nov; 93(1115):20200257. PubMed ID: 32706980
[TBL] [Abstract][Full Text] [Related]
19. [Predictive value of quantitative dynamic contrast-enhanced magnetic resonance imaging for the efficacy of neoadjuvant chemotherapy in locally advanced gastric cancer].
Zhu YJ; Li Y; Jiang J; Zhang W; Xue LY; Zhou AP; Jiang LM
Zhonghua Zhong Liu Za Zhi; 2019 Oct; 41(10):765-770. PubMed ID: 31648499
[No Abstract] [Full Text] [Related]
20. Prognostic value of tumoral and peritumoral magnetic resonance parameters in osteosarcoma patients for monitoring chemotherapy response.
Hao Y; An R; Xue Y; Li F; Wang H; Zheng J; Fan L; Liu J; Fan H; Yin H
Eur Radiol; 2021 May; 31(5):3518-3529. PubMed ID: 33146792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
